Company profilePharmaceutical#631 of 1,318 in Pakistan✓ No DRAP alerts

JAENS PHARMACEUTICAL INDUSTRIES PVT LTD DML: 000532

Pharmaceutical company · 17 brands · 35 molecules

Ranked #99 of 108 companies in Macrolides, Lincosamides And Streptogramins

17 registered products 12 pharmaceutical brands 35 distinct molecules 0 DRAP alerts

Company overview

17
registered products
12
pharmaceutical brands
35
distinct molecules
1
therapeutic classes
0
DRAP alerts

JAENS PHARMACEUTICAL INDUSTRIES PVT LTD DML: 000532 is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 17 product registrations across 35 distinct molecules. Its portfolio is concentrated in Macrolides, Lincosamides And Streptogramins. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Letrozole ...... 2.5 Mg1 brand
Letrozole1 brand
Methylprednisolone Aceponate ...... 0.1 % W1 brand
Metronidazole ...... 200 Mg1 brand
Metronidazole ...... 400 Mg1 brand
Hydroxychloroquine ...... 200 Mg1 brand
Cefixime ...... 400 Mg1 brand
Cefixime1 brand

Therapeutic classes

Macrolides, Lincosamides And Streptogramins · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official23 products · Rs 38.01 – Rs 4,521.02
Median across source: Rs 427.65

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.16 shared molecules
NEUTRO PHARMA (PVT) LTD.15 shared molecules
ALLMED LABORATORIES13 shared molecules
Pharmasol (Pvt) Ltd.13 shared molecules
MEDISAVE PHARMACEUTICALS13 shared molecules
SEARLE PAKISTAN (PVT.) LTD.12 shared molecules

Get the full profile for JAENS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.